Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation

The flow of substances between the blood and the central nervous system is precisely regulated by the blood–brain barrier (BBB). Its disruption due to unbalanced blood glucose levels (hyper- and hypoglycemia) occurring in metabolic disorders, such as type 2 diabetes, can lead to neuroinflammation, a...

Full description

Bibliographic Details
Main Authors: Anna D. Grabowska, Mateusz Wątroba, Joanna Witkowska, Agnieszka Mikulska, Nuno Sepúlveda, Dariusz Szukiewicz
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/14/11640
_version_ 1797588960920207360
author Anna D. Grabowska
Mateusz Wątroba
Joanna Witkowska
Agnieszka Mikulska
Nuno Sepúlveda
Dariusz Szukiewicz
author_facet Anna D. Grabowska
Mateusz Wątroba
Joanna Witkowska
Agnieszka Mikulska
Nuno Sepúlveda
Dariusz Szukiewicz
author_sort Anna D. Grabowska
collection DOAJ
description The flow of substances between the blood and the central nervous system is precisely regulated by the blood–brain barrier (BBB). Its disruption due to unbalanced blood glucose levels (hyper- and hypoglycemia) occurring in metabolic disorders, such as type 2 diabetes, can lead to neuroinflammation, and increase the risk of developing neurodegenerative diseases. One of the most studied natural anti-diabetic, anti-inflammatory, and neuroprotective compounds is resveratrol (RSV). It activates sirtuin 1 (SIRT1), a key metabolism regulator dependent on cell energy status. The aim of this study was to assess the astrocyte SIRT1 response to neuroinflammation and subsequent RSV treatment, depending on systemic glycemia. For this purpose, we used an optimized in vitro model of the BBB consisting of endothelial cells and astrocytes, representing microvascular and brain compartments (MC and BC), in different glycemic backgrounds. Astrocyte-secreted SIRT1 reached the highest concentration in hypo-, the lowest in normo-, and the lowest in hyperglycemic backgrounds. Lipopolysaccharide (LPS)-induced neuroinflammation caused a substantial decrease in SIRT1 in all glycemic backgrounds, as observed earliest in hyperglycemia. RSV partially counterbalanced the effect of LPS on SIRT1 secretion, most remarkably in normoglycemia. Our results suggest that abnormal glycemic states have a worse prognosis for RSV-therapy effectiveness compared to normoglycemia.
first_indexed 2024-03-11T00:59:29Z
format Article
id doaj.art-3519e9c472534ff2a19b0a059a485797
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T00:59:29Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-3519e9c472534ff2a19b0a059a4857972023-11-18T19:42:37ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-07-0124141164010.3390/ijms241411640Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to NeuroinflammationAnna D. Grabowska0Mateusz Wątroba1Joanna Witkowska2Agnieszka Mikulska3Nuno Sepúlveda4Dariusz Szukiewicz5Laboratory of the Blood-Brain Barrier, Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, PolandLaboratory of the Blood-Brain Barrier, Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, PolandLaboratory of the Blood-Brain Barrier, Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, PolandLaboratory of the Blood-Brain Barrier, Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, PolandFaculty of Mathematics and Information Science, Warsaw University of Technology, Koszykowa 75, 00-662 Warsaw, PolandLaboratory of the Blood-Brain Barrier, Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, PolandThe flow of substances between the blood and the central nervous system is precisely regulated by the blood–brain barrier (BBB). Its disruption due to unbalanced blood glucose levels (hyper- and hypoglycemia) occurring in metabolic disorders, such as type 2 diabetes, can lead to neuroinflammation, and increase the risk of developing neurodegenerative diseases. One of the most studied natural anti-diabetic, anti-inflammatory, and neuroprotective compounds is resveratrol (RSV). It activates sirtuin 1 (SIRT1), a key metabolism regulator dependent on cell energy status. The aim of this study was to assess the astrocyte SIRT1 response to neuroinflammation and subsequent RSV treatment, depending on systemic glycemia. For this purpose, we used an optimized in vitro model of the BBB consisting of endothelial cells and astrocytes, representing microvascular and brain compartments (MC and BC), in different glycemic backgrounds. Astrocyte-secreted SIRT1 reached the highest concentration in hypo-, the lowest in normo-, and the lowest in hyperglycemic backgrounds. Lipopolysaccharide (LPS)-induced neuroinflammation caused a substantial decrease in SIRT1 in all glycemic backgrounds, as observed earliest in hyperglycemia. RSV partially counterbalanced the effect of LPS on SIRT1 secretion, most remarkably in normoglycemia. Our results suggest that abnormal glycemic states have a worse prognosis for RSV-therapy effectiveness compared to normoglycemia.https://www.mdpi.com/1422-0067/24/14/11640blood–brain barrierastrocytesglycemianeuroinflammationsirtuin 1resveratrol
spellingShingle Anna D. Grabowska
Mateusz Wątroba
Joanna Witkowska
Agnieszka Mikulska
Nuno Sepúlveda
Dariusz Szukiewicz
Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
International Journal of Molecular Sciences
blood–brain barrier
astrocytes
glycemia
neuroinflammation
sirtuin 1
resveratrol
title Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
title_full Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
title_fullStr Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
title_full_unstemmed Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
title_short Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
title_sort interplay between systemic glycemia and neuroprotective activity of resveratrol in modulating astrocyte sirt1 response to neuroinflammation
topic blood–brain barrier
astrocytes
glycemia
neuroinflammation
sirtuin 1
resveratrol
url https://www.mdpi.com/1422-0067/24/14/11640
work_keys_str_mv AT annadgrabowska interplaybetweensystemicglycemiaandneuroprotectiveactivityofresveratrolinmodulatingastrocytesirt1responsetoneuroinflammation
AT mateuszwatroba interplaybetweensystemicglycemiaandneuroprotectiveactivityofresveratrolinmodulatingastrocytesirt1responsetoneuroinflammation
AT joannawitkowska interplaybetweensystemicglycemiaandneuroprotectiveactivityofresveratrolinmodulatingastrocytesirt1responsetoneuroinflammation
AT agnieszkamikulska interplaybetweensystemicglycemiaandneuroprotectiveactivityofresveratrolinmodulatingastrocytesirt1responsetoneuroinflammation
AT nunosepulveda interplaybetweensystemicglycemiaandneuroprotectiveactivityofresveratrolinmodulatingastrocytesirt1responsetoneuroinflammation
AT dariuszszukiewicz interplaybetweensystemicglycemiaandneuroprotectiveactivityofresveratrolinmodulatingastrocytesirt1responsetoneuroinflammation